ANIXA BIOSCIENCES, INC. Shares Issued, Shares, Share-based Payment Arrangement, Forfeited
ANIXA BIOSCIENCES, INC. (ANIX) reported Shares Issued, Shares, Share-based Payment Arrangement, Forfeited of 2.00 million shares for the 6-month period ending 2025-04-30, per its 10-Q filed 2025-05-28.
Financial Statements › Shareholders' Equity › Shares Granted or Issued, Share-Based Payment Arrangement
us-gaap:StockIssuedDuringPeriodSharesShareBasedCompensationForfeited · last filed 2025-05-28
- 2025-04-30: Shares Issued, Shares, Share-based Payment Arrangement, Forfeited 6 month 2.00M shares.
| Period end | Shares Issued, Shares, Share-based Payment Arrangement, Forfeited 6 month |
|---|---|
| 2025-04-30 | 2.00M shares 10-Q · filed 2025-05-28 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| CITIUS ONCOLOGY, INC. (CTOR) | United States | $0.097B | -1.49 |
| Milestone Pharmaceuticals Inc. (MIST) | $0.098B | -2.00 | |
| Acrivon Therapeutics, Inc. (ACRV) | United States | $0.091B | -1.03 |
| ProMIS Neurosciences Inc. (PMN) | $0.102B | ||
| Rallybio Corp (RLYB) | United States | $0.089B | |
| Polaryx Therapeutics, Inc. (PLYX) | United States | $0.106B | |
| ONCOLYTICS BIOTECH INC (ONCY) | $0.086B | ||
| NEONC TECHNOLOGIES HOLDINGS, INC. (NTHI) | United States | $0.086B | |
| Biomea Fusion, Inc. (BMEA) | United States | $0.107B | -3.30 |
| Lexaria Bioscience Corp. (LEXX) | $0.084B | -1.92 |